Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,760 | 12,817 | 13,162 | 26,934 | 16,801 |
| Marketable Securities | 32,715 | 37,482 | 42,587 | 36,459 | 41,067 |
| Receivables | 3,373 | 3,078 | 2,452 | 1,213 | 981 |
| TOTAL | $48,843 | $54,991 | $59,519 | $66,203 | $60,305 |
| Non-Current Assets | |||||
| PPE Net | 810 | 854 | 844 | 802 | 822 |
| Other Non-Current Assets | 133 | 232 | 139 | 139 | 140 |
| TOTAL | $943 | $1,086 | $983 | $941 | $962 |
| Total Assets | $49,786 | $56,077 | $60,502 | $67,144 | $61,267 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 763 | 389 | 615 | 634 | 267 |
| Accrued Expenses | 5,002 | 5,220 | 4,212 | 3,713 | 3,639 |
| TOTAL | $5,765 | $5,629 | $4,877 | $4,418 | $3,957 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 20 | 50 | 71 | 51 |
| Other Non-Current Liabilities | 101 | 111 | 117 | 122 | 127 |
| TOTAL | $101 | $111 | $117 | $122 | $127 |
| Total Liabilities | $5,866 | $5,740 | $4,994 | $4,540 | $4,084 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 874 | 669 | 666 | 658 | 538 |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -80,632 | -72,513 | -66,030 | -58,156 | -51,524 |
| Other shareholders' equity | -98 | -102 | -32 | -29 | -37 |
| TOTAL | $43,920 | $50,337 | $55,508 | $62,604 | $57,183 |
| Total Liabilities And Equity | $49,786 | $56,077 | $60,502 | $67,144 | $61,267 |